About: Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases in the United States. It develops oxylanthanum carbonate, a lanthanum-based phosphate binding agent, which is for the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis; and UNI-494, a nicotinamide ester derivative and a selective ATP-sensitive mitochondrial potassium channel activator, which is in Phase I clinical trial for the treatment of acute kidney injury and pre-clinical stage for the treatment of chronic kidney disease. The company was incorporated in 2016 and is headquartered in Mountain View, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $5.12 (+1.79%)
UNCYNASDAQUnicycive Therapeutics Inc
Unicycive Therapeutics Inc share price
UNCY price activity
Último preço
$ 5,120
Variação (24h)
0,09 USD (1,79%)
Volume
906.73K
Volume (média 4 sem.)
-
Abertura
$ 5,04
Variação do dia
$ 5,01 - $ 5,14
Fechamento anterior
$ 5,03
Último negócio
09 Sep, 8:00 pm GMT+0
Atrasado
09 Sep, 8:00 pm GMT+0
UNCY price performance
Atrasado
09 Sep, 8:00 pm GMT+0
quote.marketSignals